19 research outputs found

    Kinetic modeling of H-mode pedestal with effects from anomalous transport and MHD stability

    No full text
    Scaling of the H-mode pedestal in tokamak plasmas with type I ELMs and dependence of the pedestal properties and the resulting divertor head load width with the plasma elongation and plasma current are investigated using the kinetic neoclassical XGC0 code for DIII-D and Alcator C-Mod tokamaks. The simulations in this study use realistic diverted geometry and are self-consistent with the inclusion of kinetic neoclassical physics, theory-based anomalous transport models with the E×B flow shearing effects, as well as an MHD ELM triggering criterion. Scalings for the pedestal width and height are developed as a function of the scanned plasma parameters. The nonlinear interplay between anomalous and neoclassical effects motivates the development of a self-consistent simulation model that includes neoclassical and anomalous effects simultaneously. It is demonstrated that the divertor heat load width depend on the plasma currents. In the development of this dependence, effects of neutral collisions and anomalous transport are taken into account. Changes in the neoclassical divertor heat load fluxes associated with the introduction of the neutral collision and anomalous transport effects are described.За допомогою кінетичного неокласичного коду XGC0 для розрядів в токамаках DIII-D і Alcator C-Mod досліджено скейлінг п’єдесталу в плазмі, що перебуває в режимі поліпшеного утримання, з прикордонними локалізованими модами (ПЛМ) першого типу, властивості п’єдесталу і потоку тепла на дивертор в залежності від витягнутості плазми та струму плазми. У розрахунках використовуються: реалістична геометрія дивертора, кінетична модель для неокласичних ефектів, модель аномального транспорту, яка враховує ефекти шира (ExB)-потоків, і умови збудження ПЛМ-нестійкостей. У результаті розрахунків отримані скейлінгі для ширини і висоти п’єдесталу як функції параметрів плазми. Нелінійна взаємодія неокласичних ефектів і ефектів, пов'язаних з аномальним транспортом, є мотивацією для розробки самоузгодженої чисельної моделі, яка одночасно включає ефекти аномального і неокласичного транспорту. Показано, що потоки тепла на дивертор залежать від плазмових струмів. Також представлено результати дослідження залежності напівширини профілів тепла на дивертор від ефектів, пов'язаних з аномальним транспортом і зіткненнями з нейтральними частинками.С помощью кинетического неоклассического кода XGC0 для разрядов в токамаках DIII-D и Alcator C-Mod исследованы скэйлинг пьедестала в плазме, находящейся в режиме улучшенного удержания, с приграничными локализованными модами (ПЛМ) первого типа, и зависимость свойств пьедестала и потока тепла на дивертор от вытянутости плазмы и тока плазмы. В расчетах используются: реалистичная геометрия дивертора, кинетическая модель для неоклассических эффектов, модель аномального транспорта, которая учитывает эффекты шира (ExB)-потоков, и условия возбуждения ПЛМ-неустойчивостей. В результате расчетов получены скэйлинги для ширины и высоты пьедестала как функции параметров плазмы. Нелинейное взаимодействие неоклассических эффектов и эффектов, связанных с аномальным транспортом, является мотивацией разработки самосогласованной численной модели, которая одновременно включает эффекты аномального и неоклассического транспорта. Показано, что потоки тепла на дивертор зависят от плазменных токов. Также представлены результаты исследования зависимости полуширины профилей тепла на дивертор от эффектов, связанных с аномальным транспортом и столкновениями с нейтральными частицами

    Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990�2015: a systematic analysis for the Global Burden of Disease Study 2015

    Get PDF
    Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. Methods We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors�the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI). Findings Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25 over the same period. All risks jointly evaluated in 2015 accounted for 57·8 (95 CI 56·6�58·8) of global deaths and 41·2 (39·8�42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million 192·7 million to 231·1 million global DALYs), smoking (148·6 million 134·2 million to 163·1 million), high fasting plasma glucose (143·1 million 125·1 million to 163·5 million), high BMI (120·1 million 83·8 million to 158·4 million), childhood undernutrition (113·3 million 103·9 million to 123·4 million), ambient particulate matter (103·1 million 90·8 million to 115·1 million), high total cholesterol (88·7 million 74·6 million to 105·7 million), household air pollution (85·6 million 66·7 million to 106·1 million), alcohol use (85·0 million 77·2 million to 93·0 million), and diets high in sodium (83·0 million 49·3 million to 127·5 million). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa. Interpretation Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden. Funding Bill & Melinda Gates Foundation. © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY licens

    Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials

    No full text
    10.1016/j.lungcan.2011.04.008Lung Cancer743469-473LUCA

    Cabazitaxel/Ipilimumab

    No full text
    corecore